BioRestorative Therapies, Inc. (OTCMKTS:BRTXQ – Get Free Report)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $1.54 and last traded at $1.50, with a volume of 11049 shares. The stock had previously closed at $1.51.
BioRestorative Therapies Trading Down 0.7 %
The firm’s 50 day moving average is $1.62 and its two-hundred day moving average is $1.60. The firm has a market cap of $2.46 billion, a P/E ratio of -1.41 and a beta of 102.36.
About BioRestorative Therapies
BioRestorative Therapies, Inc develops therapeutic products using cell and tissue protocols primarily involving adult stem cells. The company’s two core programs are related to the treatment of disc/spine disease and metabolic disorders. Its disc/spine program includes a lead cell therapy candidate, BRTX-100 is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow and intended for the non-surgical treatment of painful lumbosacral disc disorders.
See Also
- Five stocks we like better than BioRestorative Therapies
- What is the FTSE 100 index?
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- Dividend Payout Ratio Calculator
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
